Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 2 (RPL7AP2) is a processed pseudogene of the ribosomal protein L7a gene, meaning it is a non-functional genomic sequence similar to the gene encoding 60S ribosomal protein L7a. Pseudogenes do not encode functional proteins and are not considered therapeutic drug targets. RPL7AP2 does not play a known role in biological pathways or diseases; instead, it is a remnant of gene duplication or retrotransposition events and is not involved in coding functional ribosomal proteins or participating in ribosomal assembly or protein translation[1][4]. Note: This entry is not a drug target, but a pseudogene; thus, there is no relevant information for drug interaction, mechanism of action, biomarker utility, or therapeutic safety concerns. If you are searching for an actual functional ribosomal protein or an actionable target, the correct gene would be "Ribosomal protein L7a" (RPL7A), not the pseudogene RPL7AP2[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 2 (RPL7AP2).